Phenylbutazone-13C12 is used as a 13C12-labeled form of phenylbutazone for research purposes; phenylbutazone acts as a potent reductant cofactor of prostaglandin H synthase (PHS) peroxidase; it is a hepatotoxin and a non-steroidal anti-inflammatory drug (NSAID); it induces the expression of muscleblind-like protein 1 (MBNL1) and shows potential for research in ankylosing spondylitis.